Kay D. Everett

Kay D. Everett

Auto-generated profile, based on publicly available information

Kay D. Everett

The CardioVascular Center Tufts, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2023 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
KEKay D. Everett
Kay D. Everett
LSLija Swain
Lija Swain
LRLara Reyelt
Lara Reyelt
MMMonica Majumdar
Monica Majumdar
XQXiaoying Qiao
Xiaoying Qiao
NKNavin K. Kapur
Navin K. Kapur
• Transvalvular unloading with VA-ECMO (EC-Pella) is being used in patients with AMI. • VA-ECMO increases IS despite reducing LV work while EC-Pella reduces IS and LV work. • Cardioprotective signaling is activated with EC-Pella, not VA-ECMO. • EC-Pella fails to rescue mitochondrial injury due to VA-ECMO. • Load independent myocardial injury mechanisms due to VA-ECMO may be targets in AMI.

27 August 2025 in JACC: Asia
Verified
Journal Article
Open access
SHSara Hungerford
Sara Hungerford
NSNing Song
Ning Song
BLBrandon Loo
Brandon Loo
EREleanor Rye
Eleanor Rye
HSHari Sritharan
Hari Sritharan
AAAudrey I. Adji
Audrey I. Adji
Current flow (Q) assessment in aortic stenosis (AS) uses stroke volume index (SVi), a volume (V)-based measure. However, V differs fundamentally from Q, which is defined as volume per unit time (mL/s). This study evaluates the prognostic significance of volume-flow (V-Q) discordance in patients with severe AS (aortic valve area 65 years of age who underwent TAVR over 5 years (median follow-up, 3.0 years; [Q1-Q3: 3.0-3.0 years]). Aortic flow was assessed using Doppler echocardiography; transaortic flow rate (TFR) was calculated mathematically. Low V-Q discordance was defined as SVi 210 mL/s; normal V-Q discordance as SVi >35 mL/m2 with TFR <210 mL/s. V-Q discordance was observed in 29% of patients (15% low, 14% normal). Among those with SVi <35 mL/m2, discordance was more frequent in patients without hypertension (75% vs 65%), coronary disease (57% vs 35%), or diabetes (15% vs 2%; all P < 0.05). Diastolic blood pressure was lower (mean SD: 66+15 vs 59+14 mm Hg; P = 0.018), and arterial compliance was higher (median and Q1-Q3: 1.3 [1.1-1.6] vs 1.0 [0.9-1.2] mL/mm Hg; P = 0.028), independent of SVi and left ventricular ejection fraction (both P > 0.05). Low V-Q discordance was associated with improved 3-year survival (86.0% [95% CI: 72.3%-95.1%] vs 73.8% [95% CI: 64.3%-82.1%]; log-rank P = 0.030) and was a stronger survival predictor (Akaike information criterion [AIC]: 23.79; P = 0.013) than SVi <35 mL/m2 (AIC: 29.59; P = 0.047) or TFR <210 mL/s (AIC: 32.80; P = 0.049). V-Q discordance occurs in nearly one-third of patients with AS post-TAVR and offers superior prognostic value over existing SVi and TFR thresholds.

16 August 2023 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
SBShreyas Bhave
Shreyas Bhave
MEMichele Esposito
Michele Esposito
LSLija Swain
Lija Swain
XQXiaoying Qiao
Xiaoying Qiao
GMGregory Martin
Gregory Martin
NKNavin K. Kapur
Navin K. Kapur
• The authors identified a novel function role for BMP-9 in cardiac remodeling after MI. • They report that loss of BMP-9 decreases survival, increases cardiac fibrosis, and increases cardiac rupture after MI. • They observed that loss of BMP-9 increases LV MMP-9 expression and activity and also increases collagen degradation after MI.

12 October 2026 in ASAIO Journal
Verified
Journal Article
Closed access
KEKay D. Everett
Kay D. Everett
PJPankaj Jain
Pankaj Jain
ALAaron Lee
Aaron Lee
SMSatoshi Miyashita
Satoshi Miyashita
MEMichele Esposito
Michele Esposito
NKNavin K. Kapur
Navin K. Kapur
Use of Impella 5.5 in patients with decompensated heart failure-associated cardiogenic shock (ADHF-CS) is increasing as a bridge to advanced therapies. The effects of maximal trans-valvular unloading on biventricular filling and pressure–volume area (PVA) in ADHF-CS are poorly understood. Nine patients with medically refractory ADHF-CS underwent Impella 5.5 placement with simultaneous invasive arterial, venous, and biventricular pressure–volume loop analysis. Acutely after Impella 5.5 activation, cardiac output (3.4 ± 0.5 vs. 5.0 ± 0.7 L/min, p = 0.0011), diastolic (67.2 ± 8.0 vs. 80.7 ± 9.7 mm Hg, p = 0.0044) and mean arterial pressures (77.9 ± 7.1 vs. 86.9 ± 10.4 mm Hg, p = 0.029) increased, compared to baseline. Left ventricular end-diastolic pressure (24.1 ± 6.7 vs . 16.8 ± 5.4 mm Hg, p = 0.0027), volume (262.1 ± 103.9 vs. 231.5 ± 104.3 ml, p = 0.0036), and PVA (21,913 ± 7,055 vs . 18,357 ± 7,758 mmHg·ml, p = 0.013) decreased. Right ventricular end-diastolic (12.4 ± 4.6 vs . 9.1 ± 3.8 mm Hg, p = 3.8E‐5) and end-systolic pressure (42.1 ± 11.9 vs . 34.4 ± 11.1 mm Hg, p = 0.030) and PVA (6,303 ± 3,851 vs. 4,437 ± 2,473 mm Hg·ml, p = 0.027) also decreased. These findings suggest that maximal left ventricular unloading can acutely reduce biventricular filling pressures and PVA in patients with ADHF-CS.

28 July 2025 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
KEKay D. Everett
Kay D. Everett